Literature DB >> 28238827

Rhizoma Smilacis Glabrae inhibits pathogen-induced upper genital tract inflammation in rats through suppression of NF-κB pathway.

Wei Zou1, Hougang Zhou2, Jian Hu3, Li Zhang4, Qiue Tang1, Xiaoke Wen5, Zuoqi Xiao1, Wei Wang6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Rhizoma Smilacis Glabrae (RSG) is traditionally used to treat gynecological disease, which is simply recorded in Chinese Pharmacopoeia. However, whether it has effect on upper genital tract inflammation (UGTI) is unclear. AIM OF THE STUDY: To evaluate the pharmacological effect of RSG on UGTI in rats and analyze its phytochemistry characteristics.
MATERIALS AND METHODS: The substances in RSG extract was qualified by LC-Q-TOF-MS method, and 11 substances were further quantified. The RSG extract, at dose of 241, 482 (clinical dose) and 964mg/kg/day, was orally administered to UGTI rats whose upper genital tracts were multi-infected with pathogens. Infiltrations of neutrophil and lymphocyte and productions of IL-1β, IL-6, CXCL-1, MCP-1, RANTES, PGE2, COX-2, NF-κB p65 and IκB-α in upper genital tract were examined to evaluate the effects of RSG and its potential mechanism.
RESULTS: A total of 77 substances were detected in RSG extract, with 50 substances putatively identified, most of which were flavonoids, phenolic acids and phenylpropanoids. The quantification analysis showed flavonoid had a relative high amount. In pharmacological study, RSG extract suppressed infiltrations of inflammatory cells, reduced over-productions of factors involved in inflammation and pelvic pain. A potential mechanism of these effects was blocking NF-κB signal pathway.
CONCLUSIONS: The RSG extract exhibited anti-inflammatory effect on UGTI, with a potential mechanism of blocking the activation of NF-κB signal pathway. The effect may be involved in the presence of substances, such as flavonoids and phenolic acids.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Astilbin (PubChem CID: 119258); Catechin (PubChem CID: 73160); Engeletin (PubChem CID: 12309470); L-epicatechin (PubChem CID: 1203); LC-Q-TOF-MS; NF-κB; Naringenin (PubChem CID: 932); Quercetin (PubChem CID: 5280343); Rats; Resveratrol (PubChem CID: 46782864); Rhizoma Smilacis Glabrae; Shikimic acid (PubChem CID: 8742); Syringic acid (PubChem CID: 10742); Taxifolin (PubChem CID: 471); Upper genital tract inflammation

Mesh:

Substances:

Year:  2017        PMID: 28238827     DOI: 10.1016/j.jep.2017.02.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Topical astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice via suppression dendritic cell-Th17 inflammation axis.

Authors:  Qingqing Xu; Zhaoyang Liu; Zhiqiang Cao; Yongjian Shi; Ning Yang; Guangshang Cao; Chunmin Zhang; Rong Sun; Chunhong Zhang
Journal:  J Cell Mol Med       Date:  2022-01-12       Impact factor: 5.310

2.  Flavonoid Group of Smilax glabra Roxb. Regulates the Anti-Tumor Immune Response Through the STAT3/HIF-1 Signaling Pathway.

Authors:  Yingxue Guo; Weiye Mao; Lu Jin; Linying Xia; Jie Huang; Xia Liu; Ping Ni; Qiyang Shou; Huiying Fu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

3.  Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease.

Authors:  Wuyuntana Wang; Huan Wang
Journal:  Biol Res       Date:  2019-09-06       Impact factor: 5.612

4.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.